Healthcare & pharma industry
Keep public healthcare market evidence current, traceable, and review-ready.
Give market access, regulatory, R&D, and directory-quality teams source-linked trial updates, medicine and regulatory data, formulary and public pricing pages, provider directories, supply notices, safety communications, and research records.
Public-data scope only. No patient data, PHI, diagnosis, medical advice, treatment recommendations, patient profiling, eligibility decisions, or clinical decisions.
Decision workflow · healthcare pharmaReady
01
Define the public source universe
Name jurisdictions, registries, authorities, page families, and exclusions.
02
Preserve identifiers and revisions
Keep source-native keys, dates, evidence, relationship states, and history.
03
Choose the operating boundary
Infrastructure, API access, recurring feed, or managed public-data program.
Decision coverage
Six healthcare decisions. One traceable public evidence layer.
Each team needs different public sources and fields. Every team needs the same answer to: where did this value come from, when was it stated, what changed, and what remains uncertain?
01
R&D & competitive intelligence
Map trials and development activity.
Which public trials, interventions, sponsors, phases, sites, and source-reported statuses relate to a therapeutic area or program?
Registry and trial ID
Sponsor, intervention and phase
Source-reported status history
02
Regulatory & medical affairs
Follow public medicine records and revisions.
What do public labels, assessment reports, approvals, safety notices, and recalls state across authorities and jurisdictions?
Medicine and document IDs
Authority and jurisdiction
Effective and revision dates
03
Market access & reimbursement
Compare public pricing and coverage context.
Where are products, packs, list prices, formulary positions, and coverage-policy statements publicly presented?
Product, pack and market
Plan or document context
Displayed and effective dates
04
Commercial, supply & portfolio operations
Observe public product and supply changes.
How are drug, device, and over-the-counter products listed, and which public shortage, recall, or availability statements changed?
Product identity and seller
Market and displayed availability
Source state and revision
05
Provider & network strategy
Track public directory evidence.
Which public provider and facility identifiers, organizations, specialties, locations, and contact fields are presented by approved directories?
NPI or jurisdictional ID
Organization, specialty and location
Source and observation dates
06
Research, evidence & public-health teams
Assemble reproducible public source panels.
Which publications, reports, metadata records, and aggregate institutional sources support a documented research question?
Publisher and identifier
Publication and revision dates
Provenance and collection state
Public-source coverage
Define the public evidence universe before collecting a record.
Coverage starts with an approved source panel, named entities, jurisdictions, fields, contexts, dates, access constraints, rights, and explicit exclusions.
Source families
Public Trials & sponsor disclosures Registries, study records, sponsor pages and results
Public Regulatory & medicine records Labels, assessments, approvals, recalls and shortages
Review Pricing, formulary & product pages Displayed prices, packs, coverage documents and listings
Review Providers, facilities & research Directories, publications and institutional reports
Approved public evidence brief
Required context
01 Entity & identifier Trial, drug, product, provider, facility, authority
02 Market context Jurisdiction, market, pack, dose, plan, language
03 Evidence time Posted, effective, updated and observed dates
04 Rights & quality Provenance, access, relationship and collection states
Operating boundary
记录
General public-page access, browser rendering, search, proxies, and documented API behavior for approved requests.
飞行员先
Healthcare-source eligibility, entity matching, multilingual records, PDFs and tables, revisions, pricing context, document history, and recurring delivery.
没有标准
EHRs, claims, member portals, patient records, PHI, patient profiling, diagnosis, medical advice, treatment recommendations, eligibility, or clinical decisions.
Public availability does not mean unrestricted reuse. Source terms, copyright, database rights, privacy, traffic, jurisdiction, retention, and downstream purpose still require review.
Inspectable data contract
Keep the source statement, identifier, date, and limits together.
A normalized field is ready for qualified review only when the original value, source-native key, jurisdictional context, evidence date, relationship state, and collection outcome remain reviewable.
01 · Entity identity
Which public object is this?
Trial registry ID, drug or substance ID, product and pack key, provider or facility ID, sponsor, authority, and source URL.
02 · Source observation
What did the source state?
Title, status, phase, intervention, ingredient, dose, price, formulary, provider, facility, recall, shortage, and document fields.
03 · Context & time
Where and when did it apply?
Jurisdiction, market, product form, pack, plan or document context, source posted, effective, updated, and observed timestamps.
04 · Provenance & quality
Can a reviewer reconstruct it?
Raw and normalized values, rule and schema version, exact or candidate links, conflicts, missing cues, artifacts, revisions, and collection failures.
Illustrative trial observation Fictional — not patient or customer data
- record_id
trial_obs_example_001
- registry
ClinicalTrials.gov
- nct_id
NCT########
- sponsor
Example Biopharma
- intervention
Example compound
- phase
PHASE2
- overall_status
RECRUITING
- source_updated
2026-07-28
- observed_at
2026-07-30T08:15:00Z
- program_link_state
candidate
- missing_cues
[authoritative_product_id]
- clinical_assessment
not_provided
Source reported Candidate link Not a clinical assessment
Entity identity & history
Resolve the evidence without inventing relationships.
Use source-native identifiers first. Keep every inferred link and every observed revision explicit so buyers can distinguish source truth from analytical interpretation.
01
Anchor exact identifiers
Prefer trial, drug, substance, product, provider, facility, organization, and document IDs before names or descriptions.
02
Build canonical reference entities
Represent drug, ingredient, brand, strength, pack, trial, sponsor, site, provider, facility, and payer entities separately.
03
Label every relationship
Use exact, candidate, conflicting, unresolved, and excluded states. Never silently merge records because names look similar.
04
Append temporal evidence
Keep effective, posted, verified, updated, first-seen, last-seen, and observed times distinct, with prior versions retained.
Registry, regulatory, pricing, coverage, safety, provider, and research fields remain source-specific. Your qualified medical, regulatory, reimbursement, research, and governance teams determine their meaning and use.
Relationship chain Review state: candidate
Trial identity
NCT########
Exact registry key · source status retained
Intervention
Example compound
Source-reported name · no product ID
Program association
Orenda-21
Candidate link · missing authoritative cue
Qualified review
Customer decision
Evidence supplied · clinical meaning not inferred
Quality & inference boundary
A public record is not a clinical conclusion.
Separate source-reported facts, normalized values, relationship confidence, revisions, missing observations, failed collection, and customer interpretation.
Trial record history NCT########
4 observations
12 Jul · registry Status reported as recruiting Observed
19 Jul · registry No source-field change Observed
28 Jul · registry Enrollment field revised Changed
30 Jul · collector Registry request did not complete Failed
观察到
Source returned the agreed fields
The value is traceable to the public record and observation context.
Revised or candidate
A value changed or a link needs review
The prior state and supporting or missing cues remain available.
没有观察到
No eligible record appeared
This does not prove absence, discontinuation, ineligibility, unavailability, or any clinical state.
Failed
Collection did not complete
No medical, regulatory, access, provider, safety, or research conclusion follows from a failed request.
WebScrapingAPI observes
Public source records
Displayed fields, public documents, source identifiers, evidence dates, revisions, artifacts, and collection states.
Contracted processing adds
Structure and history
Extraction, normalization, entity keys, explicit relationship states, revision tracking, quality checks, and delivery.
Your qualified teams determine
Meaning and action
Medical, clinical, regulatory, reimbursement, safety, research, privacy, eligibility, and every downstream decision.
Trial records
Source-reported, not validated science
A registry entry or status does not establish scientific validity, efficacy, safety, approval, or availability.
Safety reports
Reports do not establish causality
Public adverse-event observations do not prove that a product caused an event or establish incidence.
Market and provider records
Context is not eligibility or quality
A price, formulary, or directory field does not prove patient cost, coverage, authorization, credentialing, network participation, or care quality.
Four operating models
Choose how public healthcare evidence enters your workflow.
Each model separates WSA-operated public-data work from your source-rights review, privacy and clinical governance, qualified interpretation, and downstream decisions.
Maximum collection control
Run your own approved public-source collectors through proxy infrastructure.
WebScrapingAPI operates the contracted proxy-network features. Your team owns source rights and privacy review, collectors, request logic, extraction, entity resolution, schedules, quality, maintenance, retention, delivery, medical interpretation, and decisions.
Proxy infrastructure ownership for healthcare data
Lifecycle responsibility Owner
Purpose, source rights, privacy & clinical governance 你的团队
Proxy routing, rotation & contracted location options WSA
Collectors, extraction, entity links & evidence 你的团队
Scheduling, quality, maintenance, retention & delivery 你的团队
Medical, regulatory, access, safety & research decisions 你的团队
Maintained public-page access
Request eligible public sources without operating the access layer.
WebScrapingAPI maintains the documented API service, including supported routing, retries, rendering, screenshots, and endpoint schema. Your team owns the source brief, schedule, raw-response parsing where needed, cross-source identity and history unless contracted, governance, interpretation, and decisions.
Web access API ownership for healthcare data
Lifecycle responsibility Owner
Purpose, approved sources, rights, privacy & review rules 你的团队
API access, routing, retries & supported rendering WSA
Extraction & schema returned by the endpoint By endpoint
Scheduling, cross-source identity, history & downstream quality 你的团队
Privacy, medical, regulatory, access & research decisions 你的团队
Recurring public-record delivery
Receive agreed public healthcare records in one scheduled schema.
WebScrapingAPI operates contracted source collection, extraction, normalization, maintenance, schedule, quality checks, and delivery. Entity matching, relationship states, evidence artifacts, and history are included when specified.
Scheduled healthcare feed ownership
Lifecycle responsibility Owner
Purpose, source panel, fields, rights & acceptance rules Your team + WSA
Eligible-source access, collection & extraction WSA when contracted
Normalization, entity matching, evidence & history WSA when contracted
Scheduling, quality, source maintenance & delivery WSA
Privacy, interpretation, governance & downstream decisions 你的团队
Operated public-data program
Hand off the contracted public-source collection operation.
Bring the approved public-data purpose, entities, jurisdictions, sources, fields, cadence, identity rules, safeguards, and destination. WebScrapingAPI designs and operates the agreed collection and delivery workflow with your team.
Managed healthcare data ownership
Lifecycle responsibility Owner
Purpose, lawful authority, rights, privacy & clinical governance 你的团队
Eligible-source onboarding, collection & document handling WSA when contracted
Extraction, normalization, identity, evidence & history WSA when contracted
Scheduling, quality, maintenance, exceptions & delivery WSA
Medical, regulatory, access, privacy & research decisions 你的团队
Representative public-data pilot
Prove the scope with public records—and ambiguity included.
Start with one therapeutic area, market, or operational question. Test exact and candidate links, revisions, conflicting dates, missing fields, unavailable sources, exclusions, and failed collection before scaling.
- 01 · Frame
Define purpose and boundaries
Choose entities, jurisdictions, public sources, fields, evidence dates, rights, privacy controls, cadence, and destination.
- 02 · Sample
Collect representative states
Include stable records, source revisions, exact and candidate links, conflicting values, documents, missing fields, exclusions, and failures.
- 03 · Validate
Agree the data contract
Review identifiers, raw and normalized values, relationship rules, revision history, quality states, evidence, and acceptance criteria.
- 04 · Operate
Launch the right handoff
Assign collection and maintenance ownership, connect delivery, monitor source continuity, and preserve privacy and qualified-review controls.
The pilot validates public-data collection and the evidence contract—not a medical, clinical, regulatory, reimbursement, safety, or research conclusion.
Evaluation questions
What healthcare and pharma teams should confirm before collection.
Public source scope, identifiers, dates, relationship states, privacy, clinical limits, history, maintenance, and delivery ownership—answered directly.
Which public healthcare and pharmaceutical sources can be covered?
Eligible sources can include public trial registries, regulatory medicine databases, labels and assessment reports, pharmacy and product pages, public formulary and coverage documents, provider directories, shortage and recall notices, publication metadata, and government or institutional reports. Exact source and field coverage is validated before production.
Does this service collect patient data or PHI?
No. This industry scope excludes patient data, PHI, EHRs, claims, member portals, patient records, and individually identifiable health information.
Which healthcare and pharmaceutical fields can be delivered?
Depending on source and contract, records can include trial, sponsor, condition, intervention, phase, status and location fields; drug identifiers, ingredients, dosage forms, strengths and packs; displayed prices and formulary context; public provider identifiers, specialties and locations; source dates, provenance, and quality states.
How are drugs, trials, sponsors, providers, and facilities linked?
Exact identifiers are used first. Name, ingredient, sponsor, address, specialty, or intervention matches remain candidate links until the agreed evidence is present. Ambiguous and conflicting relationships are never silently merged.
Can trial and regulatory changes be monitored over time?
Yes, where stable public source identifiers exist. A recurring program can preserve source-reported status, label, assessment, approval, safety-notice, and document changes alongside source dates and collection time.
Can public prices, formularies, and coverage policies be tracked?
Yes, as source-specific observations with market, pack or quantity, plan or document, currency, effective date, and collection context. These records do not determine a patient’s price, coverage, eligibility, authorization, or reimbursement.
Can public safety or adverse-event sources support monitoring?
They can be collected and normalized as source-reported inputs with provenance and limitations. WebScrapingAPI does not determine causality, incidence, safety, efficacy, diagnosis, medical advice, or treatment implications.
Can provider and facility data be collected?
Public registry and directory fields can be evaluated, including identifiers, names, organizations, specialties or taxonomies, locations, and public contact information. They are not proof of licensure, credentialing, network participation, appointment availability, or quality.
How fresh can the data be, and can history be retained?
API responses reflect the requested observation time. Scheduled or managed cadence depends on the source and scope. History begins when recurring collection begins unless a validated historical source is separately included.
Who maintains collection and decides how the data may be used?
Proxy customers maintain their collectors; WebScrapingAPI maintains the documented API layer; and WebScrapingAPI maintains contracted collection and delivery for scheduled or managed programs. The customer’s legal, privacy, medical, regulatory, and governance teams retain responsibility for source rights and downstream use.
Related paths
Continue with the closest healthcare data path.
Public healthcare data, clearly bounded
Validate one therapeutic area, provider panel, or market-access source set.
Share the public sources, entities, jurisdictions, fields, cadence, identity rules, rights requirements, safeguards, and destination. We’ll map a supportable scope and produce representative records.